Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HALOZYME THERAPEUTICS, INC. | Director | Common Stock | 194K | $7.45M | $38.49 | Apr 25, 2024 | Direct |
HALOZYME THERAPEUTICS, INC. | Director | Option to Purchase Common Stock | 8.8K | $122K | $13.87 | Apr 25, 2024 | Direct |
SUTRO BIOPHARMA, INC. | Director | Stock Option (right to buy) | 35K | Jun 6, 2024 | Direct | ||
ARTELO BIOSCIENCES, INC. | Director | Stock Option (right to buy) | 1.08K | Feb 28, 2024 | Direct |